World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
60
Citations
15862
World Ranking
3304
National Ranking
33

Yusen Zhou publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Yusen Zhou sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 153 publications — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Yusen Zhou D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Yusen Zhou sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 60 D-Index — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Yusen Zhou was a researcher affiliated with Zhengzhou University in China. Their academic work focused primarily on the field of Medicine, with an emphasis on Infectious Diseases, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine, and Neurology. Zhou's research contributions spanned 33 publications in Medicine, including 18 on Infectious Diseases and a number addressing Molecular Biology and Immunology.

The scientist's main research topics covered areas related to SARS-CoV-2 and COVID-19, notably including clinical studies, animal virus infections, autoimmune disorders, and long-term effects of COVID-19. Zhou's work also explored pharmacovigilance and adverse drug reactions. Specific themes within their research included:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Animal Virus Infections Studies
  • Tuberculosis Research and Epidemiology
  • Immunodeficiency and Autoimmune Disorders
  • Long-Term Effects of COVID-19
  • Pharmacovigilance and Adverse Drug Reactions

Several recent papers illustrate the scope and direction of Zhou's research. These include:

  • Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine, 2020, Cellular and Molecular Immunology
  • Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy, 2020, Science
  • SARS-CoV-2 invades host cells via a novel route: CD147-spike protein, 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • Highly sensitive and specific detection of hepatitis B virus DNA and drug resistance mutations utilizing the PCR-based CRISPR-Cas13a system, 2020, Clinical Microbiology and Infection
  • CRISPR-Cas13a Cleavage of Dengue Virus NS3 Gene Efficiently Inhibits Viral Replication, 2020, Molecular Therapy - Nucleic Acids

Zhou had frequent collaborations with several scholars in their research field, most notably:

  • Guangyu Zhao
  • Shibo Jiang
  • Yong-Qiang Deng
  • Shihui Sun
  • Jiangliu Yin

The scientist published their work in multiple venues known for infectious disease and virology research, including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Research Square (Research Square)
  • Frontiers in Pharmacology
  • SSRN Electronic Journal
  • Cellular and Molecular Immunology

Best Publications

  • The spike protein of SARS-CoV — a target for vaccine and therapeutic development

    Lanying Du;Yuxian He;Yusen Zhou;Shuwen Liu

  • Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.

    Wanbo Tai;Lei He;Xiujuan Zhang;Jing Pu;Jing Pu

  • Molecular mechanism for antibody-dependent enhancement of coronavirus entry

    Yushun Wan;Jian Shang;Shihui Sun;Wanbo Tai

  • Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy.

    Hongjing Gu;Qi Chen;Guan Yang;Lei He

  • A Mouse Model of SARS-CoV-2 Infection and Pathogenesis.

    Shi Hui Sun;Qi Chen;Hong Jing Gu;Guan Yang

  • Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine.

    Yuxian He;Yusen Zhou;Shuwen Liu;Zhihua Kou

  • Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus

    Jie Zhou;Cun Li;Guangyu Zhao;Hin Chu

  • Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies.

    Yuxian He;Hong Lu;Pamela Siddiqui;Yusen Zhou

  • MERS-CoV spike protein: a key target for antivirals

    Lanying Du;Yang Yang;Yusen Zhou;Lu Lu

  • Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development

    Lanying Du;Guangyu Zhao;Zhihua Kou;Cuiqing Ma

  • A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines

    Lanying Du;Zhihua Kou;Cuiqing Ma;Xinrong Tao

  • Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV

    Yuting Jiang;Guangyu Zhao;Nianping Song;Pei Li

  • Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model.

    Lanying Du;Guangyu Zhao;Yuxian He;Yan Guo

  • Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines.

    Yuxian He;Yusen Zhou;Hao Wu;Baojun Luo

  • A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV.

    Guangyu Zhao;Lanying Du;Cuiqing Ma;Ye Li

  • Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines

    Cuiqing Ma;Ye Li;Lili Wang;Guangyu Zhao

  • Intranasal Vaccination of Recombinant Adeno-Associated Virus Encoding Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Spike Protein Induces Strong Mucosal Immune Responses and Provides Long-Term Protection against SARS-CoV Infection

    Lanying Du;Guangyu Zhao;Yongping Lin;Hongyan Sui

  • Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity

    Lanying Du;Guangyu Zhao;Chris C.S. Chan;Shihui Sun

  • Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry

    Yuxian He;Yusen Zhou;Pamela Siddiqui;Shibo Jiang

  • In silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations.

    Yi Yang;Weilai Sun;Jingjing Guo;Guangyu Zhao

  • Research and development of universal influenza vaccines

    Lanying Du;Yusen Zhou;Shibo Jiang

Frequent Co-Authors

Shibo Jiang
Shibo Jiang Fudan University
Lanying Du
Lanying Du Georgia State University
Yuxian He
Yuxian He Peking Union Medical College Hospital
Bo-Jian Zheng
Bo-Jian Zheng University of Hong Kong
Fang Li
Fang Li University of Minnesota
Chien Te K. Tseng
Chien Te K. Tseng The University of Texas Medical Branch at Galveston
Stephen Tomlinson
Stephen Tomlinson Medical University of South Carolina
Lu Lu
Lu Lu Fudan University
Kwok-Yung Yuen
Kwok-Yung Yuen University of Hong Kong
C.C. Chan
C.C. Chan University of Hong Kong

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related health science careers often begin with foundational nursing degrees. Many students explore the best online BSN programs for non nurses to make a seamless transition into nursing. These programs cater to individuals without prior nursing experience, offering flexible paths into healthcare roles closely aligned with immunological research and patient care.

Accelerated options also appeal to career changers and motivated learners. The nurse practitioner accelerated program is designed to fast-track advanced clinical roles, allowing graduates to work directly with immune-compromised patients or specialize in infectious diseases and immunotherapy treatments.

When selecting a program, accessibility and entry requirements are vital considerations. If you’re looking for less competitive options, exploring the easiest ABSN to get into can provide a quicker route to earning a nursing degree, while those targeting entry-level licensure may prefer investigating which LPN programs are easiest to get into. These pathways can serve as stepping stones toward more specialized immunology-related careers.

Combining immunology expertise with nursing credentials offers a dynamic career pathway in healthcare, research, and patient education, making these online degrees a practical choice for aspiring professionals.

Best Scientists Citing Yusen Zhou

Recently Published Articles